Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
2 drugs for “Extensive-Stage Small Cell Lung Cancer”
Approved 1
- TarlatamabAMGEN INCExtensive Stage Small-cell Lung Cancer; Extensive-Stage Small-Cell Lung Cancer
Phase 3 1
- BMS-986489BRISTOL MYERS SQUIBB COExtensive-Stage Small Cell Lung Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.